MedPath

Injection of Hyaluronic Acid versus Corticosteroid in Management of Plantar Fasciitis: Randomized Clinical Trial

Phase 4
Conditions
Musculoskeletal Diseases
Registration Number
PACTR202401785557046
Lead Sponsor
Mohammed VI University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Age: 20 and 60 years
Chronic talalgia (3 months), resistant to conservative treatment: rest, insoles, physical treatment (such as deep transverse massages, stretching, shock waves, etc.), and NSAIDs.
Clinical diagnosis of PA: Pain initiated or aggravated by exertion and pain on palpation of the enthesis.
Absence of fissures detected in ultrasound examinations.
Visual Analog Scale (VAS) pain > 3/10

Exclusion Criteria

Plantar fascia surgery
Shock waves within the last 3 months
A corticosteroid or PRP injection in the last 3 months
Bilateral plantar fasciitis
Uncontrolled diabetes mellitus
Chronic inflammatory rheumatism (spondyloarthritis)
Tarsal tunnel syndrome
Infection or local trauma near the injection site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity will be assessed by : The Visual Analogue Scale (VAS)<br><br><br>
Secondary Outcome Measures
NameTimeMethod
Function will be assessed by : Roles and Maudsley score and Functional Foot Index (FFI); Ultrasound evaluation: Measurement of AP thickness / Absence of fissures;Patient satisfaction using Satisfaction likert scale;Complications: Fissure/rupture, infection
© Copyright 2025. All Rights Reserved by MedPath